Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00080743 | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | completed | Phase 2 | 2 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | completed | Phase 2 | 250 | Hospital San Carlos, MadridOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00169000 | Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers | completed | Phase 1 | 12 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00952679 | Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients | unknown | Phase 3 | 50 | Fudan UniversityOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00354900 | Phase I Study of Aprotinin in Advanced Breast Cancer | terminated | Phase 1 | 18 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00156039 | Randomized Trial of Follow-up Strategies in Breast Cancer | completed | Phase 4 | 968 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00582322 | Genetic Studies in Breast Cancer | completed | — | 483 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 20, 2009 | clinicaltrials |
| NCT00759837 | Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects | completed | Phase 1 | 27 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 16, 2009 | clinicaltrials |
| NCT00638599 | Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer(LMATBBC) | completed | Phase 4 | 200 | Nanjing Medical UniversityOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00940199 | PASSION - P Trial: Ph Adjusted Sulfur-Colloid, Sentinel Initiative ON Pain Trial(PassionP) | completed | — | 140 | Walter Reed Army Medical CenterFED | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00938171 | Comparing Local Anesthesia With General Anesthesia for Breast Cancer Surgery | unknown | Phase 3 | 40 | Mackay Memorial HospitalOTHER | 1 | Jul 13, 2009 | clinicaltrials |
| NCT00582803 | Adherence to Intensive Surveillance for Hereditary Breast Cancer | completed | — | 85 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00824876 | Orthostatic Tolerance in Mamma Cancer Patients After Anaesthesia | completed | — | — | Rigshospitalet, DenmarkOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00606931 | Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast Abnormalities(PEM-BX) | completed | N/A | 22 | Naviscan PET SystemsINDUSTRY | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00842998 | Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer(HERLAP) | unknown | Phase 2 | 120 | Azienda Ospedaliera Ordine Mauriziano di TorinoOTHER | 1 | Jun 26, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00687648 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | unknown | Phase 2 | 70 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00801411 | Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 318 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00912548 | Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women(ASTRRA) | unknown | Phase 3 | 1,234 | Korean Breast Cancer Study GroupOTHER | 1 | Jun 16, 2009 | clinicaltrials |
| NCT00912639 | A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer | unknown | Phase 4 | 90 | Korean Breast Cancer Study GroupOTHER | 1 | Jun 16, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | completed | Phase 2 | 47 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00306631 | A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 | completed | Phase 2 | 65 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
| NCT00429871 | Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer | completed | Phase 3 | 272 | Hellenic Oncology Research GroupOTHER | 1 | May 29, 2009 | clinicaltrials |
| NCT00909649 | Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy(MRM) | completed | N/A | 50 | Mansoura UniversityOTHER | 1 | May 28, 2009 | clinicaltrials |
| NCT00452140 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 5 | May 19, 2009 | clinicaltrials |
| NCT00784862 | ATAC - Pharmacokinetics (PK) Sub-Protocol | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | May 15, 2009 | clinicaltrials |
| NCT00902954 | Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer(LEANEX) | unknown | Phase 3 | 540 | Fudan UniversityOTHER | 1 | May 15, 2009 | clinicaltrials |
| NCT00193908 | Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream | completed | Phase 3 | 333 | Trans Tasman Radiation Oncology GroupOTHER | 1 | May 14, 2009 | clinicaltrials |
| NCT00079248 | Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer | unknown | N/A | — | Institute of Cancer Research, United KingdomOTHER | 1 | May 12, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | completed | Phase 3 | 448 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00814125 | ATAC - Endometrial Sub-Protocol | completed | Phase 3 | 285 | AstraZenecaINDUSTRY | 0 | May 1, 2009 | clinicaltrials |
| NCT00003135 | Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | unknown | Phase 2 | 34 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00234403 | A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00247481 | ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer | completed | Phase 2 | 77 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00255463 | Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study | completed | Phase 2 | 185 | AstraZenecaINDUSTRY | 7 | Apr 23, 2009 | clinicaltrials |
| NCT00637026 | Ph II Early BC Pre-Surgical Biologic Study | completed | Phase 2 | 65 | AstraZenecaINDUSTRY | 0 | Apr 23, 2009 | clinicaltrials |
| NCT00241462 | Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients(FORUM) | terminated | — | 150 | AstraZenecaINDUSTRY | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00632723 | IRESSA™ (Gefitinib) in Breast Cancer Patients | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 0 | Apr 22, 2009 | clinicaltrials |
| NCT00643513 | Quality Of Life While Receiving Faslodex | completed | — | 120 | AstraZenecaINDUSTRY | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00635713 | Second Line Breast Cancer Trial | completed | Phase 3 | 588 | AstraZenecaINDUSTRY | 0 | Apr 10, 2009 | clinicaltrials |
| NCT00497458 | Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects(ART2) | unknown | Phase 2 | 90 | Havah Therapeutics Pty LtdINDUSTRY | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00294996 | Trial of Myocet in Metastatic Breast Cancer | unknown | Phase 3 | 363 | Sopherion TherapeuticsINDUSTRY | 11 | Mar 31, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Aug 6, 2009source: clinicaltrials